Accunea
1 known investors
Accunea develops organ condition monitoring technology that tracks biomarkers of kidney function and metabolism before and after transplantation, providing clinicians with continuous point-of-care data and AI-driven trend analysis. It serves transplant centres and clinicians to assess organ viability and support patient recovery, and integrates with hospital EPR systems.
AI & Machine LearningHealthtechMedical Devices